AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

biote Corp. (BTMD)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

4.79

-0.11 (-2.24%)

At close: Feb 20, 2025, 3:59 PM

4.78

-0.21%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	4.57
Market Cap	260.27M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.3
PE Ratio (ttm)	15.97
Forward PE	n/a
Analyst	Buy

Ask	4.99
Volume	109,051
Avg. Volume (20D)	145,026.2
Open	4.86
Previous Close	4.90
Day's Range	4.71 - 4.95
52-Week Range	4.45 - 8.44
Beta	undefined

About BTMD

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was fou...

[Show more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Apr 28, 2021

Employees 194

Stock Exchange NASDAQ

Ticker Symbol BTMD

Website https://biote.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for BTMD stock is "Buy." The 12-month stock price forecast is $10.5, which is an increase of 119.21% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

biote Corp. is scheduled to release its earnings on Mar 11, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

6 months ago

-18.91%

Biote shares are trading lower after the company r... Unlock content with Pro Subscription

9 months ago

-1.91%

Biote shares are trading lower after J Capital issued a short report on the stock.

News

2 months ago · zacks.com

Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?

Here is how biote Corp. (BTMD) and Doximity (DOCS) have performed compared to their sector so far this year.

2 months ago · zacks.com

Should Value Investors Buy biote Corp. (BTMD) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 months ago · zacks.com

Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect?

The mean of analysts' price targets for biote Corp. (BTMD) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among anal...

2 months ago · zacks.com

Are Investors Undervaluing biote Corp. (BTMD) Right Now?

3 months ago · zacks.com

biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for biote Corp. (BTMD), indicating that the stock has found support. This, combined with an upward trend in earnings estimate rev...